Alkermes
ALKS
#3107
Rank
$4.83 B
Marketcap
$29.30
Share price
-0.78%
Change (1 day)
-5.67%
Change (1 year)

Market capitalization of Alkermes (ALKS)

Market cap: $4.83 Billion USD

As of December 2025 Alkermes has a market cap of $4.83 Billion USD. This makes Alkermes the world's 3107th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alkermes from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025$4.83 B1.19%
2024$4.78 B3.28%
2023$4.62 B7.82%
2022$4.29 B14.15%
2021$3.76 B18.46%
2020$3.17 B-1.36%
2019$3.21 B-29.97%
2018$4.59 B-45.39%
2017$8.41 B-0.36%
2016$8.44 B-29.39%
2015$11.96 B38.46%
2014$8.63 B54.21%
2013$5.60 B128.45%
2012$2.45 B9.02%
2011$2.24 B92.17%
2010$1.17 B31.76%
2009$0.88 B-12.34%
2008$1.01 B-35.22%
2007$1.56 B15.9%
2006$1.34 B-22.94%
2005$1.75 B37.65%
2004$1.27 B5.84%
2003$1.20 B195.65%
2002$0.40 B-76.04%
2001$1.69 B-5.51%
2000$1.79 B43.27%
1999$1.25 B166.94%
1998$0.46 B13.24%
1997$0.41 B-3.65%
1996$0.43 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Alkermes was reported to be:

$4.83 Billion USD
by Nasdaq info icon info icon
$4.83 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Acorda Therapeutics
ACOR
$0.82 M-99.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$105.75 B 2,086.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$487.83 B 9,983.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$146.12 B 2,920.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$279.14 B 5,669.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
$32.59 B 573.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Zogenix
ZGNX
$1.50 B-68.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$119.36 B 2,367.19%๐Ÿ‡ซ๐Ÿ‡ท France
Novartis
NVS
$254.10 B 5,152.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland